Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Post-Transplant Lymphoproliferative Disorders
Vikas R. Dharnidharka
Department of Pediatrics
Division of Nephrology, Hypertension & Apheresis
Institute of Clinical and Translational Sciences (ICTS)
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Post-Transplant Lymphoproliferative Disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Post-transplant Lymphoproliferative Disorder
100%
Immunosuppression
33%
B Cells
16%
Cell Proliferation
16%
Chemotherapy
16%
Management Strategy
16%
Transformed Cells
16%
Organ Transplantation
16%
Lymphoma
16%
Non-Hodgkin Lymphoma
16%
Lymphoid Cells
16%
Epstein-Barr
16%
Clinical Presentation
16%
Preventive Measures
16%
Risk-adjusted
16%
Transplant Immunosuppression
16%
Epstein-Barr Virus Infections
16%
Severe Cases
16%
B-lineage
16%
Organ Transplant
16%
Preemptive Intervention
16%
Tumor Localization
16%
Hodgkin
16%
Heterogenous Groups
16%
DNAemia
16%
Anti-B
16%
Medicine and Dentistry
Posttransplant Lymphoproliferative Disease
100%
Immunosuppressive Treatment
50%
B Cell
33%
Cell Proliferation
16%
Organ Transplantation
16%
Non-Hodgkin Lymphoma
16%
Lymphoid Cell
16%
Histopathology
16%
Epstein Barr Virus
16%
Epstein-Barr Virus Infection
16%
Cell Lineage
16%
Tumor Localization
16%
Transformed Cell
16%
Cell Antibody
16%
Immunology and Microbiology
Lymphoproliferative Disorders
100%
Immunosuppression
50%
B Cell
33%
Epstein Barr Virus
33%
Organ Transplantation
16%
Viral Disease
16%
Cell Lineage
16%
Cell Proliferation
16%
Transformed Cell
16%
Innate Lymphoid Cell
16%
Cell Antibody
16%